Home >> Research Area >> Ropivacaine hydrochloride monohydrate

Ropivacaine hydrochloride monohydrate

anaesthetic, long-acting and local CAS# 132112-35-7

Ropivacaine hydrochloride monohydrate

Catalog No. BCC5169----Order now to get a substantial discount!

Product Name & Size Price Stock
Ropivacaine hydrochloride monohydrate:5mg $68.00 In stock
Ropivacaine hydrochloride monohydrate:10mg $116.00 In stock
Ropivacaine hydrochloride monohydrate:25mg $272.00 In stock
Ropivacaine hydrochloride monohydrate:50mg $476.00 In stock
Related Products
  • JNJ-26481585

    Catalog No.:BCC2147
    CAS No.:875320-29-9
  • TC-H 106

    Catalog No.:BCC2426
    CAS No.:937039-45-7
  • KD 5170

    Catalog No.:BCC2420
    CAS No.:940943-37-3

Quality Control of Ropivacaine hydrochloride monohydrate

Number of papers citing our products

Chemical structure

Ropivacaine hydrochloride monohydrate

3D structure

Chemical Properties of Ropivacaine hydrochloride monohydrate

Cas No. 132112-35-7 SDF Download SDF
PubChem ID 6918111 Appearance Powder
Formula C17H29ClN2O2 M.Wt 328.88
Type of Compound N/A Storage Desiccate at -20°C
Solubility H2O : 14 mg/mL (42.57 mM; Need ultrasonic and warming)
Chemical Name (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide;hydrate;hydrochloride
SMILES O.[Cl-].CCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C.[H+]
Standard InChIKey VSHFRHVKMYGBJL-CKUXDGONSA-N
Standard InChI InChI=1S/C17H26N2O.ClH.H2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;;/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H;1H2/t15-;;/m0../s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Ropivacaine hydrochloride monohydrate Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Ropivacaine hydrochloride monohydrate Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Ropivacaine hydrochloride monohydrate

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.0406 mL 15.2031 mL 30.4062 mL 60.8125 mL 76.0156 mL
5 mM 0.6081 mL 3.0406 mL 6.0812 mL 12.1625 mL 15.2031 mL
10 mM 0.3041 mL 1.5203 mL 3.0406 mL 6.0812 mL 7.6016 mL
50 mM 0.0608 mL 0.3041 mL 0.6081 mL 1.2162 mL 1.5203 mL
100 mM 0.0304 mL 0.152 mL 0.3041 mL 0.6081 mL 0.7602 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Ropivacaine hydrochloride monohydrate

Ropivacaine hydrochloride monohydrate is an effective, long-acting and local anaesthetic [1].

In COS-7 cells, Ropivacaine hydrochloride monohydrate has been reported to inhibit the the SUR2A/Kir6.2 channel currents. The inhibitory effects of Ropivacaine have shown be concentration-dependent and reversible because the channel currents recovered after washout. Furthermore, the IC50 values of Ropivacaine hydrochloride monohydrate are 249±11, 2235±115, 2442±132 and 2375±179μM for SUR2A/Kir6.2, SUR2B/Kir6.1, SUR2B/Kir6.2 and Kir6.2△C36, respectively. Apart from these, Ropivacaine hydrochloride monohydrate has also demonstrated to inhibit sarcolemmal KATP channels in the cardiovascular system by a stereoselective and tissue-specific way[2].

References:
[1] Reiz S1, Häggmark S, Johansson G, Nath S. Cardiotoxicity of ropivacaine--a new amide local anaesthetic agent. Acta Anaesthesiol Scand. 1989 Feb;33(2):93-8.
[2] Kawano T1, Oshita S, Takahashi A, Tsutsumi Y, Tomiyama Y, Kitahata H, Kuroda Y, Nakaya Y. Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on sarcolemmal adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Anesthesiology. 2004 Aug;101(2):390-8.

Featured Products
New Products
 

References on Ropivacaine hydrochloride monohydrate

Lack of metabolic racemisation of ropivacaine, determined by liquid chromatography using a chiral AGP column.[Pubmed:7640170]

Chirality. 1995;7(4):272-7.

Ropivacaine hydrochloride monohydrate (ropivacaine) is a new local anaesthetic agent which is administered exclusively as the (-)-(S)-form. The aim of the study was to determine whether metabolic racemisation of (-)-(S)-ropivacaine occurs. This was tested in man, rat, dog, and sheep after different routes of administration. The enantiomers of ropivacaine and two of the major metabolites, 3-hydroxy-ropivacaine and 2',6'-pipecoloxylidide (PPX), were determined in urine samples by liquid chromatography on a Chiral AGP column after liquid-liquid extraction. It was possible to detect < 1% of the (+)-(R)-enantiomer of both ropivacaine and the two major metabolites. In the samples examined, no trace of metabolic racemisation was observed. In pharmacokinetic, pharmacodynamic, toxicological, and metabolic studies, therefore, nonchiral assays are considered to be adequate.

Description

Ropivacaine hydrochloride monohydrate is a sodium channel inhibitor. Ropivacaine hydrochloride monohydrate blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.

Keywords:

Ropivacaine hydrochloride monohydrate,132112-35-7,Natural Products, buy Ropivacaine hydrochloride monohydrate , Ropivacaine hydrochloride monohydrate supplier , purchase Ropivacaine hydrochloride monohydrate , Ropivacaine hydrochloride monohydrate cost , Ropivacaine hydrochloride monohydrate manufacturer , order Ropivacaine hydrochloride monohydrate , high purity Ropivacaine hydrochloride monohydrate

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: